$QBIO News Article - Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed's Strontium89, its FDA Approved Drug for the Non-Opioid Treatment of Metastatic Cancer in the Bone
https://marketwirenews.com/news-releases/q-bi...28116.html